Skip to Content

SHARE

Clinical Trials Details

Studying Interventions on the Management of Patients with Chronic Myeloid Leukemia (CML)

CA180-330, Chronic Myeloid Leukemia In Chronic Phase: The 5-Year Prospective Cohort Study

Objective

This study is looking at 3 cohorts of patients with Chronic Myeloid Leukemia (CML) treated with imatinib, dasatinib or nilotinib to look at disease management and patient outcomes.  Questionnaire are mailed or emailed to be completed every six months for 5 years.

IRB Protocol Number
CA180330
Principal Investigator(s)
Brock Whittenberger, MD
Sponsor(s)
Simplicity
Contact
Linda Allen, RN OCN at 406-435-7481
or lallen@billingsclinic.org

Location

  • Billings Clinic Hospital Fountain Courtyard - South of the Hospital Cafeteria
    2750 9th Ave North
    Billings, MT 59101